JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

B4660 PI-3065

Target: PI3K

Summary: P110δkinase inhibitor

≥22.7 mg/mL
A8210 GDC-0941
10 Citation

Target: PI3K

Summary: PI3K inhibitor,potent and selective

≥25.7 mg/mL
A8250 LY 294002
16 Citation

Target: PI3K

Summary: Potent PI3K inhibitor
A2846 OSU-03012 (AR-12)
1 Citation

Target: PDK-1

Summary: Potent PDK1 inhibitor

≥23 mg/mL
A5112 XL147

Target: PI3K

Summary: PI3K inhibitor,selective and reversible

≥22.45 mg/mL
A2681 TGX-221

Target: PI3K

Summary: PI3Kβ inhibitor,potent,selective and ATP competitive

insoluble in H2O; insoluble in EtOH; ≥68.7 mg/mL
A2552 Quercetin dihydrate

Target: PI3K|PIM1 kinase|phospholipase A2

Summary: PLA2 and PI 3-kinase inhibitor

≥33.8 mg/mL
A5072 GSK690693

Target: Akt|PKC|PKG|PKA|Prk

Summary: Pan-AKT inhibitor,ATP-competitive and potent

≥21.25 mg/mL
A5653 AT7867

Target: Akt|PKA|p70 rsk

Summary: Akt1/2/3 and p70S6K/PKA inhibitor

≥16.9 mg/mL
A8214 AZD8055
2 Citation

Target: mTOR

Summary: MTOR inhibitor

≥23.3 mg/mL